Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand

Rheumatology

Volumn 49, Issue 10, 2010, Pages 1867-1877

  Szodoray, Peter ^a   Alex, Philip ^b   Knowlton, Nicholas ^c   Centola, Michael ^c   Dozmorov, Igor ^c   Csipo, Istvan ^d   Nagy, Annamaria T ^d   Constantin, Tamas ^e   Ponyi, Andrea ^e   Nakken, Britt ^f   Danko, Katalin ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

A proliferation inducing ligand; B cell activating factor; Circulating cytokines; Idiopathic inflammatory myopathies

Indexed keywords

ALPHA INTERFERON; APRIL PROTEIN; B CELL ACTIVATING FACTOR; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MALE; MULTIVARIATE ANALYSIS; MYOSITIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; SCHOOL CHILD; T LYMPHOCYTE; UNIVARIATE ANALYSIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; B-CELL ACTIVATING FACTOR; CHEMOKINES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; MYOSITIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77956857329     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq151     Document Type: Article

References (51)

1. Wortmann RL. Inflammatory diseases of mucle and other myopathies. In: Harris ED, Budd RC, Firestein GS et al., eds. Kelley's textbook of rheumatology. 7th edition. Philadelphia: Elsevier Saunders, 2005:1309-35.
2. Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 2004;83:35-42.
3. Cronin ME, Plotz PH. Idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1990;16:655-65.
4. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002;28:779-98.
5. Grundtman C, Lundberg IE. Pathogenesis of idiopathic inflammatory myopathies. Curr Rheumatol Rep 2006;8: 188-95.
6. Rider LG, Miller FW. Idiopathic inflammatory myopathies: pathology and pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, White PH, eds. Primer on the rheumatic diseases. New York: Springer, 2008, pp. 368-74.
7. Aleksza M, Szegedi A, Antal-Szalmás P et al. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis 2005; 64:1485-9.
8. Lindberg C, Oldfors A, Tarkowski A. Local T-cell proliferation and differentiation in inflammatory myopathies. Scand J Immunol 1995;41:421-6.
9. Lundberg I, Brengman JM, Engel AG. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 1995;63:9-16.
10. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:940-8.
11. Wolf RE, Baethge BA. Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 1990;33:1007-14.
12. Fang CH, Li BG, James JH, Fischer JE, Hasselgren PO. Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover. Shock 1997;8:362-7.
13. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999;129:227S-37S.
14. Quinn LS, Haugk KL, Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 1995;136:3669-72.
15. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998;113:407-14.
16. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
17. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-15.
18. Hahne M, Kataoka T, Schröter M et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;188:1185-90.
19. Moore PA, Belvedere O, Orr A et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999;285:260-3.
20. Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 1999;274:15978-81.
21. Schneider P, MacKay F, Steiner V et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747-56.
22. Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 1999;65:680-3.
23. Mackay F, Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 2003;14:311-24.
24. Zhang M, Ko KH, Lam QL et al. Novel function of TNF cytokines in regulating bone marrow B cell survival. Cell Mol Immunol 2004;1:447-53.
25. Huard B, Arlettaz L, Ambrose C et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 2004;16:467-75.
26. Huard B, Schneider P, Mauri D, Tschopp J, French LE. T cell costimulation by the TNF ligand BAFF. J Immunol 2001;167:6225-31.
27. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005;25:189-201.
28. Seyler TM, Park YW, Takemura S et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005;115: 3083-92.
29. Stohl W, Metyas S, Tan SM et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 2003; 48:3475-86.
30. Toubi E, Shoenfeld Y. BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus. Isr Med Assoc J 2004;6:99-102.
31. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
32. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
33. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
34. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 1976;55: 193-215.
35. Michet CJJ, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986;104: 74-8.
36. Vitali C, Bombardieri S, Jonsson R et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
37. Ruperto N, Ravelli A, Pistorio A et al. Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008;59:4-13.
38. Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, DankóK. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology 2005;44:83-8.
39. Alex P, Szodoray P, Knowlton N et al. Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis. Clin Exp Rheumatol 2007;25: 584-92.
40. Szodoray P, Alex P, Chappell-Woodward CM et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology 2007;46:417-25.
41. Nix B, Wild D. The immunoassay handbook. Elsevier Science, 2005.
42. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
43. Jackson JE. A user's guide to principal components (Wiley Series in Probability and Statistics). Wiley-Interscience, 2003.
44. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd edition. Wiley-Interscience, 2002.
45. Jarvis JN, Dozmorov I, Jiang K et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2004;6: R15-32.
46. de Padilla CM, Reed AM. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2008;20:669-74.
47. Civatte M, Bartoli C, Schleinitz N, Chetaille B, Pellissier JF, Figarella-Branger D. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 2005;31:70-9.
48. Dong C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 2008;226: 80-6.
49. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-41.
50. KrystufkováO, Vallerskog T, Helmers SB et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 2009;68:836-43.
51. Alex P, Zachos NC, Nguyen T et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009;15: 341-52.